ARTICLE | Company News
Insight Genetics, Qiagen deal
January 14, 2013 8:00 AM UTC
Insight granted Qiagen exclusive, worldwide rights to ret proto-oncogene (RET), c-ros proto-oncogene 1 receptor tyrosine kinase (ROS1) and DEP domain containing 1 (DEPDC1) biomarkers as an aid in d...